Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(2.50)
# 2,446
Out of 5,090 analysts
134
Total ratings
54.22%
Success rate
-1.69%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Outperform | $28 → $30 | $23.84 | +25.84% | 5 | Nov 7, 2025 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $28 | $17.49 | +60.09% | 1 | Nov 7, 2025 | |
| DOCS Doximity | Maintains: Outperform | $81 → $70 | $45.93 | +52.41% | 10 | Nov 7, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $83 → $90 | $73.62 | +22.25% | 2 | Nov 5, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $190 → $220 | $198.83 | +10.65% | 10 | Oct 31, 2025 | |
| TDOC Teladoc Health | Maintains: In-Line | $9 → $8 | $7.59 | +5.40% | 6 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Outperform | $85 → $95 | $75.63 | +25.61% | 10 | Oct 30, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $160 → $170 | $157.21 | +8.14% | 15 | Oct 30, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: In-Line | $17 → $13 | $11.25 | +15.56% | 8 | Oct 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $220 → $240 | $225.85 | +6.27% | 7 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $50.04 | +29.90% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4 → $3 | $2.60 | +15.38% | 9 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $7 → $11 | $14.24 | -22.75% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $190 | $182.51 | +4.10% | 4 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $305 | $258.39 | +18.04% | 7 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $800 → $825 | $808.62 | +2.03% | 7 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $23 | $20.23 | +13.69% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $5 → $3 | $0.65 | +359.98% | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $36 | $34.35 | +4.80% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $68 → $26 | $3.03 | +766.34% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $35 → $15 | $3.81 | +293.70% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $11 | $1.39 | +691.37% | 2 | Jan 4, 2022 |
Privia Health Group
Nov 7, 2025
Maintains: Outperform
Price Target: $28 → $30
Current: $23.84
Upside: +25.84%
Omada Health
Nov 7, 2025
Maintains: Outperform
Price Target: $27 → $28
Current: $17.49
Upside: +60.09%
Doximity
Nov 7, 2025
Maintains: Outperform
Price Target: $81 → $70
Current: $45.93
Upside: +52.41%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $83 → $90
Current: $73.62
Upside: +22.25%
Cardinal Health
Oct 31, 2025
Maintains: Outperform
Price Target: $190 → $220
Current: $198.83
Upside: +10.65%
Teladoc Health
Oct 30, 2025
Maintains: In-Line
Price Target: $9 → $8
Current: $7.59
Upside: +5.40%
CVS Health
Oct 30, 2025
Maintains: Outperform
Price Target: $85 → $95
Current: $75.63
Upside: +25.61%
Align Technology
Oct 30, 2025
Maintains: Outperform
Price Target: $160 → $170
Current: $157.21
Upside: +8.14%
DENTSPLY SIRONA
Oct 8, 2025
Maintains: In-Line
Price Target: $17 → $13
Current: $11.25
Upside: +15.56%
IQVIA Holdings
Oct 8, 2025
Maintains: Outperform
Price Target: $220 → $240
Current: $225.85
Upside: +6.27%
Oct 8, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $50.04
Upside: +29.90%
Oct 8, 2025
Maintains: In-Line
Price Target: $4 → $3
Current: $2.60
Upside: +15.38%
Oct 8, 2025
Maintains: In-Line
Price Target: $7 → $11
Current: $14.24
Upside: -22.75%
Oct 8, 2025
Maintains: In-Line
Price Target: $185 → $190
Current: $182.51
Upside: +4.10%
Oct 3, 2025
Maintains: Outperform
Price Target: $300 → $305
Current: $258.39
Upside: +18.04%
Sep 24, 2025
Maintains: Outperform
Price Target: $800 → $825
Current: $808.62
Upside: +2.03%
Jul 9, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $20.23
Upside: +13.69%
Jul 9, 2025
Maintains: In-Line
Price Target: $5 → $3
Current: $0.65
Upside: +359.98%
Nov 7, 2024
Maintains: Outperform
Price Target: $32 → $36
Current: $34.35
Upside: +4.80%
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $3.03
Upside: +766.34%
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $3.81
Upside: +293.70%
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $1.39
Upside: +691.37%